Accuracy of intramuscular injection of botulinum toxin A in juvenile cerebral palsy: A comparison between manual needle placement and placement guided by electrical stimulation

Journal of Pediatric Orthopaedics

Volumn 25, Issue 3, 2005, Pages 286-291

  Chin, Terence Y P ^a   Nattrass, Gary R ^a   Selber, Paulo ^a   Graham, H Kerr ^a,b  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Botulinum toxin; Cerebral palsy

Indexed keywords

BOTULINUM TOXIN A;

ACCURACY; ADOLESCENT; ADULT; ARTICLE; BICEPS BRACHII MUSCLE; CEREBRAL PALSY; CHILD; ELECTROSTIMULATION; FEMALE; FOREARM; GASTROCNEMIUS MUSCLE; HAMSTRING; HAND MUSCLE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NEEDLE; PRIORITY JOURNAL; SOLEUS MUSCLE; SPASTICITY; TECHNIQUE; TIBIALIS POSTERIOR MUSCLE;

ADOLESCENT; BOTULINUM TOXIN TYPE A; CEREBRAL PALSY; CHILD; CHILD, PRESCHOOL; ELECTRIC STIMULATION; FEMALE; HUMANS; INFANT; INJECTIONS, INTRAMUSCULAR; MALE; NEUROMUSCULAR AGENTS; PARALYSIS;

EID: 17844394143     PISSN: 02716798     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.bpo.0000150819.72608.86     Document Type: Article

References (31)

1. Autti-Rämo I, Larsen A, Taimo A, von Wendt L. Management of the upper limb with Botulinum toxin type A in children with spastic type cerebral palsy and acquired brain injury: clinical implications. Eur J Neurol. 2001;8(Supp. 5):136-144.
2. Boyd RN, Graham HK. Botulinum toxin A in the management of children with cerebral palsy: indications and outcome. Eur J Neurol. 1997;4(Supp. 2): 15-22.
3. Corry AP, Cosgrove AP, Walsh EG, et al. Botulinum toxin A in the hemiplegic upper limb: a double-blind trial. Dev Med Child Neurol. 1997;39:185-193.
4. Cosgrove AP, Corry IS, Graham HK. Botulinum toxin in the management of lower limb in cerebral palsy. Dev Med Child Neurol. 1994;36:386-396.
5. Fehlings D, Rang M, Glazier J, et al. An evaluation of botulinum-A toxin injections to improve upper extremity function in children with hemiplegic cerebral palsy. J Pediatr. 2000;137:331-337.
6. Koman LA, Mooney JF, Smith B, et al. Management of cerebral palsy with Botulinum A toxin: preliminary investigation. J Pediatr Orthop. 1993;13:489-495.
7. Molenaers G, Eyssen M, Desloovere K, et al. A multilevel approach to botulinum toxin A treatment of the (ilio) psoas in spasticity in cerebral palsy. Eur J Neurol. 1999;6(Supp. 4):59-62.
8. Wall SA, Chait LA, Temlett JA, et al. Botulinum A chemodenervation: anew modality in cerebral palsied hands. Br J Plast Surg. 1993;46:703-706.
9. Ward A. Botulinum toxin type A treatment of hip and thigh spasticity: a technique for injection of psoas major muscle. Eur J Neurol. 1999;6(Supp. 4):91-93.
10. Yang TF, Kao NT, Chan RC, et al. Effect of Botulinum toxin type A on cerebral palsy with upper limb spasticity. Am J Med Rehabil. 2003;82:284-289.
11. Lalli G, Herreros G, Osborne SL, et al. Functional characterization of tetanus and botulinum neurotoxins binding domains. J Cell Sci. 1999;112:2715-2724.
12. De Paiva A, Dolly JO. Light-chain of botulinum neurotoxin is active in mammalian nerve terminals when delivered by liposomes. FEBS Lett. 1990;277:171-174.
13. De Paiva A, Meunier FA, Molgo J, et al. Functional repair of motor end plates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals. Proc Natl Acad Sci USA. 1999;96:3200-3205.
14. Moore P, Naumann M. General and clinical aspects of treatment with botulinum toxin. In: Moore P, Naumann M, eds. Handbook of Botulinum Toxin Treatment. Oxford: Blackwell Science, 2003:28-75.
15. Rossetto O, Montecucco C. How botulinum toxins work. In: Moore P, Naumann M, eds. Handbook of Botulinum Toxin Treatment. Oxford: Blackwell Science, 2003:9-27.
16. O'Brien CF. Injection techniques for Botulinum toxin using electromyography and electrical stimulation. Muscle Nerve. 1997;(Supp. 6): 176-180.
17. Willenborg MJ, Shut JS, Smith BP, et al. Technique for iliopsoas ultrasound-guided active electromyography-directed botulinum A toxin injection in cerebral palsy. J Pediatr Orthop. 2002;2:165-168.
18. Boyd RN, Graham JEA, Nattrass GR, et al. Medium-term response characterization and risk factor analysis of botulinum toxin type A in the management of spasticity in children with cerebral palsy. Eur J Neurol. 1999;6(Supp. 4):37-45.
19. Couper Brash J. Neurovascular Hila of Limb Muscles. Edinburgh: E & S Livingstone, 1955.
20. Tilton AH. Injectable neuromuscular blockade in the treatment of spasticity and movement disorders. J Child Neurol. 2003;18(Supp. 1):50-65.
21. Russman BS, Tilton AH, Gormley ME Jr. Cerebral palsy: a rational approach to a treatment protocol, and the role of botulinum toxin in treatment. In: Mayer NH, Simpson DM, eds. Spasticity: Etiology, Evaluation, Management and the Role of Botulinum Toxin.2002.
22. Francisco GE, Boake C, Vaughn A. Botulinum toxin in upper limb spasticity after acquired brain injury: a randomized trial comparing dilution techniques. Am J Phys Med Rehabil. 2002;81:355-363.
23. Sloop RR, Escutin RO, Malus JA, et al. Dose-response curve of human extensor digitorum brevis muscle function to intramuscularly injected botulinum toxin type A. Neurology. 1996;46:1382-1386.
24. Ajax T, Ross MA, Rodnitzky RL. The role of electromyography in guiding botulinum toxin injections for focal dystonia and spasticity. J Neurol Rehab. 1998;12:1-4.
25. Comella CL, Buchman AS, Tanner CM, et al. Botulinum toxin injection for spasmodic torticollis: increased magnitude of benefit with electromyographic assistance. Neurology. 1992;42:878-882.
26. Molloy FM, Shill HA, Kaelin-Lang A, et al. Accuracy of muscle localization without EMG: implications for treatment of limb dystonia. Neurology. 2002;58:805-807.
27. Shaari CM, George E, Wu BL, et al. Quantifying the spread of botulinum toxin through muscle fascia. Laryngoscope. 1991;101:960-964.
28. Hallett M, Glocker F, Deuschl G. Mechanism of action of botulinum toxin [letter]. Ann Neurol. 1994;36:449-450.
29. Boyd RN, Morris ME, Graham HK. Management of upper limb dysfunction in children with cerebral palsy: a systemic review. Eur J Neurol. 2001;8(Supp. 5):150-166.
30. Shaari CM, Sanders I. Quantifying how location and dose of botulinum toxin injections affect muscle paralysis. Muscle Nerve. 1993;16:964-969.
31. Borodic GE, Ferrante R, Pearce LB, et al. Histologic assessment of dose-related diffusion and muscle fibre response after therapeutic Botulinum A toxin injections. Mov Disord. 1994;9:31-39.